TBPH - THERAVANCE BIOPHARMA INC
Healthcare · NASDAQ
Current Price
$13.15
+0.46% today
Intrinsic Value
$4.97
62.2% Overvalued
Market Cap
$652.2M
+22.2% this quarter
Smart Money Holders
9
-
Net Quarterly Flow
9 net buyers
More buying
Smart Money Signals
BUYING
100%of smart money are accumulating
Momentum Score
77▲
Smart Money Conviction
0%low
Net Flow Signal
+9net buyers
Investor Activity
0$100M+ new
Crowding Score
34
Exit Risk
0%reducing
Recent Activity
ADDEDQ2 2025
Vanguard Group
Increased position by $5.2M (+28.1%)
BUILDING
ADDEDQ2 2025
D. E. Shaw & Co
Increased position by $2.8M (+34.4%)
BUILDING
INVESTOR | LAST FILED | SHARES | % PORTFOLIO / VALUE | QUARTERLY ACTIVITY | HOLDING PERIOD | SIGNALS |
---|---|---|---|---|---|---|
D. E. Shaw & Co | 2025 Q2 | 1,001,766 | 0.01%$11M | +81K shares +$2.8M value | 5+ years | INCREASINGBUILDINGHIGH TURNOVER |
BlackRock, Inc | 2025 Q2 | 4,139,025 | 0.00%$45.7M | +688K shares +$14.8M value | 5+ years | INCREASING |
Vanguard Group | 2025 Q2 | 2,157,430 | 0.00%$23.8M | +77K shares +$5.2M value | 5+ years | INCREASINGBUILDINGHIGH TURNOVER |
Citadel Advisors | 2025 Q2 | 485,331 | 0.00%$5.4M | +47K shares +$1.4M value | 5+ years | INCREASINGBUILDINGHIGH TURNOVER |
Goldman Sachs | 2025 Q2 | 199,386 | 0.00%$2.2M | -11K shares +$319K value | 5+ years | REDUCINGHIGH TURNOVER |
JPMorgan Chase & Co | 2025 Q2 | 119,513 | 0.00%$1.3M | -37K shares -$82K value | 5+ years | REDUCING |
Two Sigma Investments | 2025 Q2 | 17,792 | 0.00%$196K | +18K shares +$196K value | 5+ years | NEW |
Point72 Asset Management | 2025 Q2 | 12,692 | 0.00%$140K | +13K shares +$140K value | 5+ years | NEW |
AQR Capital Management | 2025 Q2 | 12,249 | 0.00%$135K | +979 shares +$34K value | 5+ years | INCREASINGBUILDING |
Smart Money Activity vs Price
TOTAL BUYS
$203.5M
TOTAL SELLS
$317.1M
NET FLOW
-$113.5M
PRICE CHANGE
-32.4%
PEAK ACTIVITY
2021 Q3